GoKawiilInsight Partners' Devin Parekh defends diversified strategy over AI-lab-only bets
In a TechCrunch interview, Insight Partners co-CEO Devin Parekh discussed why the $90 billion firm has spread investments across sectors instead of concentrating heavily on frontier AI labs like OpenAI and Anthropic, even though it holds stakes in both. He also addressed missed deals such as legal-tech startup Legora, conflicts of interest in venture capital, and downplayed fears of AI-driven catastrophic risk, citing potential medical breakthroughs as a greater upside.
GoKawiil's interpretation of the reporting above, not reported fact.
As venture capital increasingly consolidates around a handful of AI labs, Insight's diversified approach represents a contrarian bet that could either miss out on outsized returns or protect against overexposure if the AI hype cycle cools. Parekh's comments also reflect a broader industry tension between VCs speaking out on every hot-button issue and firms preferring to let portfolio performance do the talking.
- Insight Partners holds stakes in both OpenAI and Anthropic but avoids betting its whole strategy on frontier AI labs.
- Parekh argues AI's benefits, especially in healthcare and drug development, outweigh risks like bioweapon misuse.
- The firm has missed some high-profile deals, including AI legal-tech startup Legora, despite its scale.
Source: techcrunch.com — Connie Loizos, 2026-09-13
Published there as: “Insight Partners’ Devin Parekh on why the firm is diversifying while everyone else bets the farm on OpenAI and Anthropic”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.